INVO Fertility reports Q2 EPS of 35 cents on higher revenue
INVO Fertility reports second-quarter diluted EPS of 35 cents, net income of $890,000 and revenue of $2.18 million, while clinic-level adjusted EBITDA doubled sequentially to about $333,000.
Major U.S. indices ended lower on Monday, with the Dow Jones Industrial Average falling 0.51% to 53,459.78, the S&P 500 declining 0.52% to 7,745.06 and the Nasdaq dropping 0.32% to 26,644.91.
These are the top stocks that gained the attention of retail traders and investors through the day: Nike Inc. (NYSE: NKE ) Nike’s stock dropped 4% to close at $39.09, with an intraday high of $40.60 and a low of $38.86.
The stock hit a new 52-week low of $38.86, significantly below its previous high of $80.16.
Nike shares fell on Monday to a fresh 52-week low of $39.41, underperforming the broader market and Consumer Discretionary sector.
The decline came after rival On Holding reported mixed second-quarter results and issued full-year 2026 sales guidance that fell slightly below expectations, raising concerns about the premium athletic-wear market.
Add article title and URL Meta Platforms Inc. (NASDAQ: META ) Meta Platforms saw its stock fall by 3.54%, closing at $568.97, with a high of $590.24 and a low of $564.75.
The stock remains below its 52-week high of $790.80 but above its low of $520.26.
The decline is attributed to legal challenges and uncertainties surrounding the company’s AI strategy.
Meta is facing allegations from 29 state attorneys general regarding data collection practices and addictive features on its platforms.
INVO Fertility Inc. (NASDAQ: IVF ) INVO Fertility’s stock surged by 60.38%, closing at $1.53, with an intraday high of $2.80 and a low of $1.41.
The stock’s 52-week range is between $0.90 and $84.40.
In the after-hours session, the stock shot up 13.73% to $1.74.
INVO Fertility reported second-quarter diluted EPS of 35 cents, far ahead of analysts’ expected 65-cent loss, while net income reached $890,000, helped by a roughly $2.5 million remeasurement gain tied to its Birmingham, Alabama clinic acquisition.
Revenue rose 17% year over year to $2.18 million, while clinic-level adjusted EBITDA doubled sequentially to about $333,000.
EyePoint Inc. (NASDAQ: EYPT ) EyePoint’s stock plummeted by 66.98%, closing at $4.87, with a high of $4.90 and a low of $3.95.
The stock’s 52-week high is $19.01, while the low is $3.95.
In the after-hours session, the stock fell 1.23% to $4.81.
EyePoint reported mixed Phase 3 LUGANO results for DURAVYU in wet AMD, missing the primary visual acuity endpoint due to a subgroup of nine patients but showing non-inferiority to aflibercept in an analysis excluding them.
The treatment also reduced the injection burden by 42%, with 54% of patients remaining supplement-free through Week 56, while the company expected second Phase 3 trial data in fourth quarter of 2026.
Micron Technology Inc. (NASDAQ: MU ) Micron’s stock rose by 4.13%, closing at $1011.75, with a high of $1036.13 and a low of $995.26.
The stock’s 52-week high is $1255, and the low is $113.47.
The increase is driven by optimistic projections from Bank of America, suggesting Micron could generate substantial free cash flow thanks to AI-driven demand for memory.
Analyst Vivek Arya projected that Micron could generate more than $640 billion in cumulative free cash flow through fiscal 2030 if AI-driven memory demand and stronger margins persisted.
The scenario could support annual share buybacks equivalent to about 10% of Micron’s market capitalization, with Arya identifying capital deployment rather than memory demand as the key risk to the thesis.
Edge Stock Rankings indicate Micron stock has a Momentum score in the 99th percentile and Value score in the 28th percentile.
Read Also: Ross Gerber Says 'Now Is a Good Time' to Buy iPhone 17 as Apple Prepares for Potential Price Hike With Next Model: 'If You're Looking…' Photo: Zakharchuk on Shutterstock.com Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published editors.